Biomerica (BMRA) Debt Ratio (2011 - 2012)

Biomerica's (BMRA) quarterly Debt Ratio came in at 0.01 in Q2 2012, up 8.08% year-on-year from 0.01 in Q2 2011, and up 233.59% quarter-over-quarter from 0.0 in Q4 2011.

Biomerica (BMRA) Debt Ratio (2011 - 2012) Analysis & Trends

Biomerica has disclosed Debt Ratio across 2 years of filings, most recently posting 0.01 for Q2 2012.

  • Debt Ratio for Q2 2012 came in at 0.01, up 8.08% year-over-year; the trailing twelve-month figure through May 2012 was 0.01 (up 8.08% YoY), and the FY2012 annual result was 0.01, up 8.08% from the prior year.
  • Debt Ratio came in at 0.01 for Q2 2012 at Biomerica, up from 0.0 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.01 in Q2 2012 to a low of 0.0 in Q4 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 0.31
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 0.32
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 0.31
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 0.25
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 0.04
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.30
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 0.27
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 0.18
10 Biomerica 5.57 Mn 4.23 Mn -44,000.00 -

Historic Data

Download Data
DateValue
May 31, 2012 0.01
Nov 30, 2011 0.00
Aug 31, 2011 0.00
May 31, 2011 0.01